Strides Pharma Science Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release

06 Sep 2024

Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300mg and 450mg

Source: BSE India

View all announcements for Strides Pharma Science Ltd